Drug
Hrs 5346
Hrs 5346: highest development phase Phase 2, developed by Shandong Suncadia Medicine Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shandong Suncadia Medicine Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| HRS-5346 NCT07767513 | Phase 2 | Lipoprotein Disorder |
Latest
No recent events.
Follow Hrs 5346 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.